TICKERNERD
Menu
BDMDBDMDHealthcare · Medical Devices

BDMD Stock Forecast: Baird Medical Investment Holdings Ltd. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$1.17
+0.86% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 10 of 100 as at 22 Aug 2026 — in the weakest quartile.

Market cap
$37.1M
Ticker Nerd rank
10 / 100
Median analyst target
—
Analysts covering
—
Total return, dividends reinvested
1W
+3.5%
1M
+7.3%
YTD
−14.0%
1Y
−41.5%
From 52W high
−66.0%
From 52W low
+51.9%
$0.77
$3.44
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BDMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Baird Medical Investment Holdings Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
10 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
82
Value
61
Accruals
46
Volatility
32
Revisions
29
Quality
15
Momentum
8
Growth
8
Issuance
2

Size (82): Smaller than most of the companies we track.

Issuance (2): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BDMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BDMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$1.50$2.00$2.50$3.00Oct 25Jan 26Apr 26Jul 26BDMD

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BDMD appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

BDMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Baird Medical Investment Holdings Ltd. (BDMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
3.2×

Cheaper than 68% of US stocks

Price / sales
1.6×

Cheaper than 58% of US stocks

Price / book
0.8×

Cheaper than 80% of US stocks

EV / EBITDA
−2.2×

Cheaper than 72% of US stocks

Growth & margins
Revenue growth (YoY)
−39.0%

Higher than 7% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
−104.1%

Higher than 13% of US stocks

Net margin
−121.0%

Higher than 5% of US stocks

Returns & dividend
Return on equity
−77.6%

Higher than 16% of US stocks

Return on assets
−21.7%

Higher than 18% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

BDMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
BDMDBaird Medical Investment Holdings Ltd.$37.1M
10
MDAISpectral AI, Inc.$49.1M
16
XTNTXtant Medical Holdings, Inc.$45.5M
83
SRTSSensus Healthcare, Inc.$54.9M
45
QTIQT Imaging Holdings, Inc.$42.6M
24
ELUTElutia, Inc.$42.1M
27
NSPRInspireMD, Inc.$42.1M
53

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Baird Medical Investment Holdings Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BDMD news & analysis

Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan

GlobeNewsWire · 20 Aug 2026positive

Baird Medical announced that its BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle received product registrations from the Drug Regulatory Authority of Pakistan (DRAP), supporting the Company's commercial activities in the country.

Why it matters — The registrations expand Baird Medical's global microwave ablation footprint and support its commercial presence in Pakistan.

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

GlobeNewsWire · 10 Aug 2026positive

Baird Medical Investment Holdings Ltd. and Tianjin Yuanshan Medical Technology Co., Ltd., operating under the Alpmed brand, have signed a strategic cooperation agreement to form a long-term partnership focused on the global development and commercialization of next-generation irreversible electroporation (IRE) technologies.

Why it matters — The partnership positions BDMD to expand its IRE technology footprint globally through collaboration with a China-based IRE innovator.

FAQ

Frequently asked questions about BDMD stock

How does Ticker Nerd's model rank BDMD?

As at 22 Aug 2026, Baird Medical Investment Holdings Ltd. ranks 10 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (82 of 100).

What is the BDMD stock forecast for 2030?

No analyst covering Baird Medical Investment Holdings Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BDMD are extrapolating price history, which says nothing about the business.

How has BDMD stock performed over the past year?

Baird Medical Investment Holdings Ltd. returned -41.5% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Baird Medical Investment Holdings Ltd. do?

Baird Medical Investment Holdings Limited is a medical devices company specializing in microwave ablation technology for minimally invasive tumor treatment. The company develops and manufactures microwave ablation apparatus, needles, and related medical devices used to treat benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, breast lumps, and bone lesions.

What is the latest news on BDMD?

The most recent item we track (GlobeNewsWire, 20 Aug 2026): "Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan". Baird Medical announced that its BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle received product registrations from the Drug Regulatory Authority of Pakistan (DRAP), supporting the Company's commercial activities in the country.

Company

About Baird Medical Investment Holdings Ltd.

Baird Medical Investment Holdings Limited is a medical devices company specializing in microwave ablation technology for minimally invasive tumor treatment. The company develops and manufactures microwave ablation apparatus, needles, and related medical devices used to treat benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, breast lumps, and bone lesions. Operating primarily in the People's Republic of China, Baird Medical positions its microwave ablation systems as safer alternatives to traditional surgical approaches, offering patients faster recovery times and lower complication rates. The company's products are FDA 510(k)-certified and have been deployed across hospitals and clinics internationally. Baird Medical distributes its microwave ablation devices and consumables through third-party distributors and maintains a focus on expanding its presence in minimally invasive medical interventions. The company also pursues research and development initiatives in surgical robotics and intelligent diagnostic systems to complement its core medical device business.

CEO Ms. Haimei Wu · 146 employees · China · https://bairdmed.com